Physician profile
Olga Libova
NPI 1316072572
$4,533.53
in general payments reported to CMS, 2019-2025
17 companies · $262 in 2025
The $262 reported for 2025 was more than what 87% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $1,511 · 2023: $2,204 · 2024: $425 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,745 · Food and Beverage: $1,146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,745.28 |
| Food and Beverage | $1,145.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,790.16 | 2023-2024 | Gemtesa, Myfembree |
| Myovant Sciences INC. | $1,104.53 | 2022 | |
| Abbvie INC. | $295.81 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $135.64 | 2024 | Ingrezza |
| Vertos Medical, INC. | $128.22 | 2022 | |
| Gilead Sciences, INC. | $125.00 | 2024 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $124.99 | 2023 | Jynarque |
| Amgen INC. | $124.97 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $121.83 | 2024 | Jynarque |
| Janssen Pharmaceuticals, INC | $109.29 | 2025 | Spravato |
| Biohaven Pharmaceuticals, INC. | $108.64 | 2021 | |
| Biogen, INC. | $106.45 | 2025 | Zurzuvae |
| Axsome Therapeutics, INC. | $98.68 | 2023 | Sunosi |
| Intercept Pharmaceuticals, INC. | $87.97 | 2023 | Ocaliva |
| Hologic Sales and Service, LLC | $28.74 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $22.41 | 2021 | |
| Becton, Dickinson and Company | $20.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Libova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.